A link between NK activity and CD69 expression was suggested by the observation that, compared with WT mice, CD69−/− mice showed an enhanced NK-mediated anti-tumour response that led to greater protection and rejection of major histocompatibility complex class I low tumour cells (Esplugues et al., 2003). This evidence concerns the gene CD69 and neoplasm.